GlassScriptPhysician profile
Bradley C Hill
NPI 1114956687
$5,637.50
in general payments reported to CMS, 2019-2025
12 companies · $911 in 2025
The $911 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $139 · 2021: $206 · 2022: $476 · 2023: $2,717 · 2024: $1,047 · 2025: $911.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,675 · Consulting Fee: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,674.83 |
| Consulting Fee | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,385.21 | 2019-2025 | Perclose Proglide, Proclaim, Octrode |
| Boston Scientific Corporation | $1,370.56 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Nevro Corp. | $313.72 | 2021-2023 | Senza |
| Stryker Corporation | $170.32 | 2025 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $118.26 | 2019-2025 | Xtampza, Belbuca |
| Abbvie INC. | $88.15 | 2024-2025 | |
| Medtronic, INC. | $44.73 | 2024 | Intellis Adaptivestim |
| Curonix LLC | $41.81 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pfizer INC. | $34.13 | 2019-2021 | |
| Lilly USA, LLC | $24.65 | 2021 | |
| Allergan, INC. | $24.46 | 2020 | |
| Si-Bone, INC. | $21.50 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.